- Research Letter
- Open Access
High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients
Critical Care volume 24, Article number: 169 (2020)
To the Editor:
We have read with great interest the Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) . We are very concerned on the recommendation to use high-flow nasal cannula (HFNC) over non-invasive positive pressure ventilation (NIPPV).
We agree that HFNC has previously demonstrated reduced 90-day mortality compared to NIPPV in patients with acute hypoxemic respiratory failure  and that NIPPV has been demonstrated to have increased risk of aerosolized transmission to health care workers . However, the differences in this risk with NIPPV compared to HFNC are largely unknown. Presently, it is known that COVID-19 (SARS-CoV-2) compared to SARS-CoV-1 remains viable in aerosols for at least 3 h with a marginal reduction in infectious titer from 103.5 to 102.7 TCID50 per liter of air . Likewise, it showed a higher stability on plastic and stainless steel than on copper and cardboard, with virus viability seen up to 72 h on these surfaces . This provides a concerning phenomenon for both HFNC and NIPPV as both interfaces are plastic with potential for aerosolization. An important difference is that the NIPPV interface provides a potential closed system (which may be advantageous) whereas HFNC allows patients to frequently touch their faces with continuous exposure to droplets, potentially increasing transmission to inanimate surfaces and hospital workers.
In 2019, Leung and colleagues found that HFNC use was not associated with increased air or contact surface bacterial contamination compared to simple oxygen mask in critically ill patients . Unfortunately, viruses were not included in this study. Likewise, the term “aerosol” is a misnomer as it is well described that larger particle droplets can remain longer in circulation if ambient airflows (as in HFNC) sustain the infectious suspension for a longer duration. This, coupled with data from influenza infections showing aerosolized viruses are infectious at a lower dose than by nasal instillation, makes use of HFNC potentially worrisome . The only known study evaluating SARS development in hospital workers was a retrospective study conducted prior to the widespread use of HFNC showing that development of SARS occurred in tracheal intubation (35%), HFNC 8%, and 38% (NIPPV) ; this suggests that both non-invasive (including HFNC) and invasive ventilation approaches carry significant risk.
Undeniably, HFNC provides more comfort to patients and likely improved compliance. However, since the data regarding transmission are unclear, we suggest, in addition to a negative pressure room, reverse isolation protection efforts with patients on HFNC wearing a mask over the nasal interface or a contained respiratory hood.
Availability of data and materials
Alhazzani W, Moller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med Released on March 20. PMID: 32224769. https://doi.org/10.1097/CCM.0000000000004363.
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New Engl J Med. 2015;372(23):2185–96.
Raboud J, Shigayeva A, McGeer A, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010;5(5):e10717.
van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7. https://doi.org/10.1056/NEJMc2004973.
Leung CCH, Joynt GM, Gomersall CD, et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect. 2019;101(1):84–7.
Alford RH, Kasel JA, Gerone PJ, et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med. 1966;122(3):800–4.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Remy, K.E., Lin, J.C. & Verhoef, P.A. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients. Crit Care 24, 169 (2020). https://doi.org/10.1186/s13054-020-02892-9